Vinay Nadkarni

Prof. Dr. Vinay Nadkarni


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2006 in JAMA
Verified
Journal Article
Open access
PDF file
VNVinay Nadkarni
Vinay Nadkarni
GLGregory Luke Larkin
Gregory Luke Larkin
MPMary Ann Peberdy
Mary Ann Peberdy
SCScott M. Carey
Scott M. Carey
WKWilliam Kaye
William Kaye
RBRobert A. Berg
Robert A. Berg
The approach to cardiopulmonary resuscitation (CPR) differs for children and adults because of presumed differences in the etiology and pathophysiology of cardiac arrests.1-4 Adults with cardiac arrest typically have sudden, unexpected ventricular fibrillation (VF) and often have underlying coronary artery disease with myocardial ischemia.5,6 The focus of adult-oriented treatment is prompt defibrillation.7 Outcomes from witnessed VF are often excellent, but outcomes from asystole and pulseless electrical activity (PEA) are generally poor.8


1 February 2015 in Resuscitation
Verified
Journal Article
Closed access
ACAdam Cheng
Adam Cheng
FOFrank Overly
Frank Overly
DKDavid Kessler
David Kessler
VNVinay Nadkarni
Vinay Nadkarni
YLYiqun Lin
Yiqun Lin
LBLinda L. Brown
Linda L. Brown

1 December 2015 in Critical Care
Verified
Journal Article
Open access
PDF file
SWScott L. Weiss
Scott L. Weiss
JFJulie C. Fitzgerald
Julie C. Fitzgerald
FMFrank A. Maffei
Frank A. Maffei
JKJason M. Kane
Jason M. Kane
ARAntonio Rodriguez-Nuñez
Antonio Rodriguez-Nuñez
FNfor the SPROUT Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
for the SPROUT Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
Introduction: Consensus criteria for pediatric severe sepsis have standardized enrollment for research studies. However, the extent to which critically ill children identified by consensus criteria reflect physician diagnosis of severe sepsis, which underlies external validity for pediatric sepsis research, is not known. We sought to determine the agreement between physician diagnosis and consensus criteria to identify pediatric patients with severe sepsis across a network of international pediatric intensive care units (PICUs). Methods: We conducted a point prevalence study involving 128 PICUs in 26 countries across 6 continents. Over the course of 5 study days, 6925 PICU patients <18 years of age were screened, and 706 with severe sepsis defined either by physician diagnosis or on the basis of 2005 International Pediatric Sepsis Consensus Conference consensus criteria were enrolled. The primary endpoint was agreement of pediatric severe sepsis between physician diagnosis and consensus criteria as measured using Cohen’s κ. Secondary endpoints included characteristics and clinical outcomes for patients identified using physician diagnosis versus consensus criteria. Results: Of the 706 patients, 301 (42.6 %) met both definitions. The inter-rater agreement (κ ± SE) between physician diagnosis and consensus criteria was 0.57 ± 0.02. Of the 438 patients with a physician’s diagnosis of severe sepsis, only 69 % (301 of 438) would have been eligible to participate in a clinical trial of pediatric severe sepsis that enrolled patients based on consensus criteria. Patients with physician-diagnosed severe sepsis who did not meet consensus criteria were younger and had lower severity of illness and lower PICU mortality than those meeting consensus criteria or both definitions. After controlling for age, severity of illness, number of comorbid conditions, and treatment in developed versus resource-limited regions, patients identified with severe sepsis by physician diagnosis alone or by consensus criteria alone did not have PICU mortality significantly different from that of patients identified by both physician diagnosis and consensus criteria. Conclusions: Physician diagnosis of pediatric severe sepsis achieved only moderate agreement with consensus criteria, with physicians diagnosing severe sepsis more broadly. Consequently, the results of a research study based on consensus criteria may have limited generalizability to nearly one-third of PICU patients diagnosed with severe sepsis.

28 February 2017 in Advances in Simulation
Verified
Journal Article
Open access
PDF file
ACAdam Cheng
Adam Cheng
DKDavid Kessler
David Kessler
RMRalph Mackinnon
Ralph Mackinnon
Todd ChangTodd Chang
Todd Chang
VNVinay Nadkarni
Vinay Nadkarni
MAMarc Auerbach
Marc Auerbach
Simulation-based research has grown substantially over the past two decades; however, relatively few published simulation studies are multicenter in nature. Multicenter research confers many distinct advantages over single-center studies, including larger sample sizes for more generalizable findings, sharing resources amongst collaborative sites, and promoting networking. Well-executed multicenter studies are more likely to improve provider performance and/or have a positive impact on patient outcomes. In this manuscript, we offer a step-by-step guide to conducting multicenter, simulation-based research based upon our collective experience with the International Network for Simulation-based Pediatric Innovation, Research and Education (INSPIRE). Like multicenter clinical research, simulation-based multicenter research can be divided into four distinct phases. Each phase has specific differences when applied to simulation research: (1) Planning phase, to define the research question, systematically review the literature, identify outcome measures, and conduct pilot studies to ensure feasibility and estimate power; (2) Project Development phase, when the primary investigator identifies collaborators, develops the protocol and research operations manual, prepares grant applications, obtains ethical approval and executes subsite contracts, registers the study in a clinical trial registry, forms a manuscript oversight committee, and conducts feasibility testing and data validation at each site; (3) Study Execution phase, involving recruitment and enrollment of subjects, clear communication and decision-making, quality assurance measures and data abstraction, validation, and analysis; and (4) Dissemination phase, where the research team shares results via conference presentations, publications, traditional media, social media, and implements strategies for translating results to practice. With this manuscript, we provide a guide to conducting quantitative multicenter research with a focus on simulation-specific issues.

6 September 2012 in Neurocritical Care
Verified
Journal Article
Open access
PDF file
ATAlexis A. Topjian
Alexis A. Topjian
RBRobert A. Berg
Robert A. Berg
JBJoost Bierens
Joost Bierens
CBChristine M. Branche
Christine M. Branche
RCRobert Clark
Robert Clark
DWDavid S. Warner
David S. Warner
Drowning is a leading cause of accidental death. Survivors may sustain severe neurologic morbidity. There is negligible research specific to brain injury in drowning making current clinical management non-specific to this disorder. This review represents an evidence-based consensus effort to provide recommendations for management and investigation of the drowning victim. Epidemiology, brain-oriented prehospital and intensive care, therapeutic hypothermia, neuroimaging/monitoring, biomarkers, and neuroresuscitative pharmacology are addressed. When cardiac arrest is present, chest compressions with rescue breathing are recommended due to the asphyxial insult. In the comatose patient with restoration of spontaneous circulation, hypoxemia and hyperoxemia should be avoided, hyperthermia treated, and induced hypothermia (32–34 °C) considered. Arterial hypotension/hypertension should be recognized and treated. Prevent hypoglycemia and treat hyperglycemia. Treat clinical seizures and consider treating non-convulsive status epilepticus. Serial neurologic examinations should be provided. Brain imaging and serial biomarker measurement may aid prognostication. Continuous electroencephalography and N20 somatosensory evoked potential monitoring may be considered. Serial biomarker measurement (e.g., neuron specific enolase) may aid prognostication. There is insufficient evidence to recommend use of any specific brain-oriented neuroresuscitative pharmacologic therapy other than that required to restore and maintain normal physiology. Following initial stabilization, victims should be transferred to centers with expertise in age-specific post-resuscitation neurocritical care. Care should be documented, reviewed, and quality improvement assessment performed. Preclinical research should focus on models of asphyxial cardiac arrest. Clinical research should focus on improved cardiopulmonary resuscitation, re-oxygenation/reperfusion strategies, therapeutic hypothermia, neuroprotection, neurorehabilitation, and consideration of drowning in advances made in treatment of other central nervous system disorders.